Novo Nordisk Pharma and Hiroshima Prefecture Conclude Cooperation Agreement for Extending Healthy Lifespan

AI Summary (NQ-processed)

Novo Nordisk Pharma Co., Ltd. and Hiroshima Prefecture signed a cooperation agreement on April 13, 2026, aimed at extending the healthy lifespan of Hiroshima residents. Chugoku Electric Power Co., Inc. also participates as a business partner in this public-private partnership. The initiative focuses on promoting correct understanding of obesity, encouraging appropriate medical consultations, and addressing related chronic diseases. The agreement also details the definitions of obesity and obesity-related diseases in Japan, including 11 specific health impairments for diagnosis.